Learn more about our Advocacy work.
Today, AdvaMed®, the medtech association, applauded the introduction in the House and Senate of the bipartisan Saving Access to Laboratory Services Act (SALSA) by Senators Sherrod Brown (D-OH) and Thom…
Today, AdvaMed®, the medtech association, released the following statement from President and CEO Scott Whitaker on the introduction of the bipartisan Ensuring Patient Access to Critical Breakthrough Products Act. The…
Each year in the U.S., ethylene oxide sterilizes 20 billion medical devices, which are critical to preventing serious, even life-threatening, infections.
AdvaMed®, the largest global trade organization representing medical technology companies, released the medtech industry’s “Medical Innovation Agenda for the 118th Congress.” These policy priorities would advance AdvaMed®’s goal to help…
AdvaMed® held a panel discussion with two member company experts on product stewardship and environmental sustainability.
The Advanced Medical Technology Association® (AdvaMed®), the largest trade association representing medical device manufacturers, including all major radiation therapy manufacturers in the U.S. and abroad. released the following statement from…
A lack of public information persists about sterilizing medical devices with ethylene oxide gas. That’s why Scott Whitaker talked with Dr. Lucy Fraiser, a board-certified toxicologist, about the facts.
From MDUFA V and the major investments in semiconductor chip manufacturing in the CHIPS Act, to addressing global supply chain issues and supporting our AdvaMed Accel® companies, 2022 was a…
The year-end spending package making its way through Congress includes key provisions championed by the Advanced Medical Technology Association® (AdvaMed®) that will benefit the patients served by the medical technology…